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ABSTRACT: Wild carnivores are often exposed to diseases via contact with peridomestic host
species that travel through the wildland-urban interfaces. To determine the antibody prevalences
and relationships to human activity for two common canid pathogens, we sampled 99 wolves
(Canis lupus) from 2000 to 2008 for antibodies to canine parvovirus (CPV) and canine distemper
virus (CDV) in Banff and Jasper National Parks and surrounding areas of the Canadian Rockies.
This population was the source for wolves reintroduced into the Northern Rockies of the US. Of 99
wolves sampled, 94 had detectable antibody to CPV (95%), 24 were antibody-positive for CDV
(24%), and 24 had antibodies to both pathogens (24%). We tested whether antibody prevalences
for CPV and CDV were higher closer to human activity (roads, town sites, First Nation reserves)
and as a function of sex and age class. Wolves $2 yr old were more likely to be have antibodies to
CPV. For CDV, male wolves, wolves $2 yr, and those closer to First Nation reserves were more
likely to have antibodies. Overall, however, we found minimal support for human influence on
antibody prevalence for CDV and CPV. The similarity between our antibody prevalence results
and results from recent studies in Yellowstone National Park suggests that at least in the case of
CDV, and perhaps CPV, these could be important pathogens with potential effects on wolf
populations.
Key words: Banff National Park, canine distemper virus, canine parvovirus, Canis lupus,
carnivore, Jasper National Park, wolf.
INTRODUCTION
Disease has been recently recognized as
a growing worldwide conservation threat
for many carnivores (Murray et al., 1999).
For example, wolves (Canis lupus) and
many other carnivores have the potential to
be exposed to canine parvovirus (CPV) and
canine distemper virus (CDV) not only
from other wolves, but also from hosts such
as domestic and feral dogs (Canis famil-
iaris) and alternate hosts such as coyotes
(Canis latrans) and red foxes (Vulpes
vulpes; Laurenson, 1998; Cleaveland
et al., 2000; Almberg et al., 2010). Preva-
lence of infection with carnivore pathogens
such as CPV and CDV tends to increase
among hosts in urban areas because of
increased contact among individuals (Wood-
roffe et al., 2004), increasing spillover
transmission rates from the reservoir hosts
for wild canids (Steinel et al., 2001). For
example, Mainka et al. (1994) found
that domestic dogs were the main source of
CPV and CDV infections in giant
pandas (Ailuropoda melanoleuca) in China.
Domestic and feral dogs have also been
identified as the major reservoir hosts for
CPV and CDV in Africa (Laurenson et al.,
1998; Cleaveland et al., 2000).
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Both CPV and CDV are primarily
spread by contact between individuals,
and they can spread rapidly because
carnivores such as wolves have high
dispersal rates, disperse over wide dis-
tances, and have large home ranges
(Murray et al., 1999; Woodroffe et al.,
2004). Canine parvovirus is often spread
through fecal-oral contact, it causes diar-
rhea, fever, and dehydration (Murray
et al., 1999; Sobrino et al., 2008), and it
infects a broad range of age classes;
however, mortality primarily occurs in
pups less than 4 mo old (Steinel et al.,
2001; Carmichael, 2005). Canine distem-
per virus is a morbillivirus that infects all
ages of canids (Sobrino et al., 2008),
causing pneumonia, encephalitis, and
sometimes death (Murray et al., 1999;
Zarnke et al., 2004). Canine parvovirus has
a lower case fatality rate than CDV
(Murray et al., 1999). For more detail
about CPV and CDV, see Murray et al.
(1999), Sobrino et al. (2008), and Almberg
et al. (2010). Both CPV and CDV infect
many carnivore species, and they are often
spread by domestic canids (Murray et al.,
1999; Woodroffe et al., 2004). Carnivore
reintroduction and restoration efforts
must therefore carefully consider disease
as an important risk factor in conservation
plans (Murray et al., 1999).
Recent wolf reintroduction success in
the western US (Bangs and Fritts, 1996;
US Fish and Wildlife Service, 2009) has
resulted in a population of over 1,500
wolves. Recently, in the Great Lakes and
Yellowstone National Park wolf popula-
tions, Mech et al. (2008) and Almberg
et al. (2009) reported evidence that CPV
and CDV infection had negative effects on
pup survival and hence population growth.
Effective wolf management plans should
acknowledge the potential population
impacts of disease outbreaks on wolves
(e.g., Montana Fish, Wildlife, and Parks,
2002). Many recovering wolf populations
are exposed to overlapping host species
and are close to human activity, potentially
increasing disease exposure. However,
compared to African carnivores, little is
known about the effects of human activity
on wolf diseases.
We examined prevalence of antibodies
to CPV and CDV in the Canadian Rockies,
the original source for reintroduced
wolves into the northwest US (Bangs and
Fritts, 1996). We predicted that preva-
lences of antibodies to both pathogens
would increase closer to human activity
(e.g., towns), because of higher population
densities of host reservoirs (domestic
dogs) and alternate hosts in valley bot-
toms. We also predicted that antibody
prevalences would be higher near First
Nation reserves, because feral dog popula-
tions associated with First Nation reserves
are often unvaccinated (e.g., Woodroffe
et al., 2004). We determined the occur-
rence of these pathogens in wolves at
varying distances from human activity
measured as distances to towns, First
Nation reserves, and roads. We examined
the effects of age and sex on CPV and CDV
antibody prevalence (Zarnke et al., 2004),
and predicted that prevalence would in-
crease with age and home range size
because of the increased likelihood of
exposure in older wolves and greater
exposure rates (Almberg et al., 2009).
MATERIALS AND METHODS
Study area
Our study area included Banff National Park,
Jasper National Park (52u15 N, 115u30 W), and
adjacent areas to the east and north (Fig. 1),
covering approximately 80,000 km2 (Thiessen,
2007). Three major highways, secondary roads,
and towns and cities occur throughout the
study area, and Jasper and Banff National Parks
each receive two to three million visitors per
year. The northern portion of the study area has
fewer residents and roads, so there is a south to
north gradient of decreasing human activity.
Within the study area, there are First Nation
reserves belonging to the Cree, Nakota Sioux,
and other First Nations peoples (Statistics
Canada, 2006). See Dekker et al. (1995) and
Hebblewhite et al. (2002) for details of the
study area.
Wolves in our study area went through two
periods of scarcity, once in the 1900s to 1920s
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because of poisoning and destruction of prey
and again in the 1950s because of poisoning
(Gunson, 1992). Starting in the 1970s, wolves
naturally recolonized our study area from
northern Alberta (Gunson, 1992; Dekker et al.,
1995). Wolves are protected from hunting and
trapping in National Parks, although they are
still subject to human-caused mortality from
road and railway mortality (Hebblewhite et al.,
2002). In both Alberta and British Columbia,
wolf management consists of liberal harvest
through hunting and trapping with the goal of
maintaining stable populations (Gunson,
1992). Population genetics research by Thies-
sen (2007) confirmed that this entire area
functions as one large population. Alternate
host species for canid diseases include feral
dogs, coyotes, mustelid species (Mustela spp.),
and occasionally red foxes. Raccoons (Procyon
lotor) do not occur.
Wolf capture and blood sampling
We captured wolves using foothold traps,
helicopter net gunning, and ground or helicop-
ter dart capture from 2000 to 2008 as part of
ongoing research projects (Hebblewhite et al.,
2002; Whittington et al., 2005; Neufeld, 2006;
Webb, 2009). Capture methods were approved
by appropriate animal care protocols (Univer-
sity of Alberta 353112, Parks Canada BNP-
004753 and JNP-2007-952, Alberta GP4816
and CN 087, WILKA101-07, British Columbia
VI07-31411). For each wolf captured, we
recorded age class, based on tooth wear
(Gipson et al., 2000), as pups and yearlings
(,2 yr) or subadults and adults ($2 yr), sex,
capture location, and wolf pack. Blood samples
were collected from jugular or cephalic veins
into serum separator tubes or silicone-coated
tubes and allowed to clot. Clotted samples were
centrifuged, and sera were pipetted into
FIGURE 1. Study area in the Canadian Rocky Mountains of Alberta–British Columbia (BC), showing
locations of wolf territories (from telemetry data) and buffered wolf (Canis lupus) capture locations (buffers)
from which wolf blood samples were analyzed for antibodies to canine distemper virus (CDV) and canine
parvovirus (CPV), 2000–2008. Locations of towns, Banff, Jasper, Kootenay, and Yoho National Park, major
roads, and First Nation Reserves are shown. Wolf data were collected during previous studies (e.g.,
Hebblewhite et al., 2002; Whittington et al., 2005; Neufeld, 2006; Webb, 2009).
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separate vials and stored at 220 C for up to 8 yr.
Sera were tested for antibodies to CPV and
CDV at the Western College of Veterinary
Medicine at Saskatoon, Saskatchewan, Canada,
using a hemagglutination inhibition assay and
virus neutralization assay (Tizzard, 2000),
respectively. Titers $1:40 were considered
positive for CPV, and titers $1:12 were
considered positive for CDV.
Human activity
Because most (90%) animals were radio-
collared, we estimated wolf pack territories
based on the 100% minimum convex polygons
(MCP; Mohr, 1947) from very high-frequency
(VHF) radio and global positioning system
(GPS) telemetry data (e.g., Hebblewhite et al.,
2002; Whittington et al., 2005; Neufeld, 2006;
Webb, 2009). We used wolf pack MCPs to
assign each pack an average human activity
level to which each individual within the pack
was assumed to be exposed. We used the MCP
rather than capture locations of individual
wolves to reflect the average exposure at the
pack level. For individual wolves from un-
known packs (n517), we drew a circular
buffer of 1,000 km2 around the capture
location to estimate exposure to human
activity. The buffer size was estimated using
the average MCP home range area across all
radiocollared packs. Measures of human
activity within each wolf pack territory were
based on average distance of each pixel in the
entire MCP to the closest paved road, First
Nation reserve, and towns. Spatial data on
human activity were obtained from the Na-
tional Topographic Survey (available at http://
geogratis.cgdi.gc.ca). We first measured dis-
tance to the three human activity layers using
the spatial analyst distance function in ARC-
GIS 9.2 (ESRI, Redlands, California, USA),
which calculates a raster distance layer (30-m2
resolution). We then measured the average
distance to paved and unimproved roads,
towns, and First Nation reserves for the entire
wolf-pack MCP using zonal statistics. We
screened for collinearity between spatial
measures of human activity, and did not
include variables if |r|.0.3 (Hosmer and
Lemeshow, 2000).
Statistical analyses
We tested our main hypotheses for the
effects of distances to human activity (towns,
roads, and First Nation reserves), age, sex, and
year on the prevalence of CPV and CDV
antibodies using logistic regression to model
the probability of a wolf being exposed to
either CDV or CPV (Hosmer and Lemeshow,
2000). We added age and sex classes to a null
model (representing constant exposure), and
added all possible combinations of individual
and combined covariates for our candidate set
of models (15 models for each). We report
odds ratios for covariates to test for effects on
antibody prevalence, and evaluated signifi-
cance at a50.1. To test our hypotheses about
the effects of human activity on exposure to
canine diseases, we predicted the coefficient
of distance to be negative if viral antibody
prevalence increased closer to human activity.
The best CDV and CPV model was selected
and compared using Akaike’s information
criteria (AIC) following Burnham and Ander-
son (1998). In the case of model selection
uncertainty, we model-averaged across the top
0–4 DAIC (Burnham and Anderson, 1998).
We also considered a random effect for each
individual pack (including unknown pack) to
accommodate potential between-pack hetero-
geneity in exposure to diseases (Gillies et al.,
2006). Despite our best field efforts, however,
wolves were not captured randomly or evenly
across the study area, which might bias disease
exposure results if age, sex, or packs varied
over time. Therefore, before statistical analy-
ses for risk factors, we conducted chi-square
(x2) tests for significant differences across time
for the sex, age, and packs that we captured
wolves from.
RESULTS
From 2000 to 2008, we sampled 99
wolves from 42 packs (Fig. 1). Only five
wolves were captured more than once,
and, because these recaptures occurred on
average 2.5 yr apart, and because the five
were not originally antibody-positive, we
considered these samples independent.
From a sampling viewpoint, there were
no significant differences in the frequency
of sexes (x2 P50.51), ages (x2 P50.31), or
packs (x2 P50.41), confirming no signifi-
cant sampling bias. Ninety-four wolves
(95%) were considered CPV antibody-
positive (titer range ,1:6–1:972) and 24
(24%) were considered CDV antibody-
positive (titer range ,1:20–1:20,480), con-
firming a higher antibody prevalence to
CPV than CDV (binomial test for overall
prevalence of CPV vs. CDV antibody
P50.001; Table 1). Pups and yearlings
had a lower CPV exposure than older
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age classes (Table 1). Female subadults
and adults had a higher probability of
exposure to CDV than male subadults and
adults (Table 1).
Effects of human activity
Model selection showed that for CPV
antibody prevalence, there were several
models between DAIC 0.0 and 2.0 (Table 2),
indicating model selection uncertainty, espe-
cially for human effects on CPV exposure.
The top models included the variables age,
sex, and distance to towns, roads, and First
Nation reserves. The null model (constant)
was DAIC57.9 and was not reported. There
was also no support for heterogeneity among
packs in exposure to CPV because the similar
model with random effects had substantially
lower model weight (DAIC54.9). Therefore,
we considered only the fixed effects from the
logistic model. Although the top model for
CPV was a function of distance to roads + age
(DAIC50.00, AIC weight50.25; Table 2),
because there was substantial model selec-
tion uncertainty, a posteriori, we model
averaged coefficients for CPV as a function
of all covariates in Table 3 (CPV as a function
of distance to towns, distance to roads,
distance to First Nation reserves, age class,
year, and sex). This ‘‘averaged’’ model was
also the best CDV model (Table 2), making
comparisons easier. The full CPV model was
marginally significant (x259.97, P50.083),
yet still explained 29.9% (pseudo R2) of
the variation in CPV antibody prevalence
(Table 3). Exposure to CPV was more likely
in subadults and adults (Table 3). Males had
slightly greater odds of exposure to CPV than
females (Table 3). Antibody prevalence to
CPV had weak and nonsignificant relation-
ships to human covariates, likely in part
because of the high prevalence of CPV
relative to CDV antibody (Table 3 and
Fig. 2).
TABLE 1. Mean and standard deviation (SD) of the prevalence (%) of antibodies to canine parvovirus (CPV)
and canine distemper virus (CDV) in wolves (Canis lupus) by age class and sex across all packs in the
Canadian Rocky Mountains of Alberta and British Columbia, 2000–2008.
Age classa and sex n CPV (%) SD CDV (%) SD
Male ,2 8 87.5 ,0.005 0 ,0.005
Male $2 35 97 0.38 17 0.12
Female ,2 9 78 ,0.005 0 ,0.005
Female $2 35 100 0.51 49 0.17
Unknowns 11 91 0.09 9 0.09
a Pups and yearlings were ,2 yr old, and subadults and adults were $2 yr of age when captured.
TABLE 2. Top canine parvovirus (CPV) and canine distemper (CDV) models for wolves (Canis lupus) in the
Canadian Rocky Mountains of Alberta and British Columbia, 2000–2008. Covariates used were age, sex, year,
and distance to human use. Model structure, sample size (n), number of parameters (K), log likelihood,
change in Akaike’s information criteria (AIC), and AIC weights are provided.
Model structure n K Log likelihood DAIC AIC weights
Top CPV models
1. Distance to road + age 75 4 211.36 0.00 0.24
2. Approximate age 75 2 212.69 0.42 0.20
3. Distance to town + age 75 4 212.07 1.41 0.12
4. Distance to road + age + sex 75 5 211.26 2.08 0.08
5. Distance to First Nation reserve + age + sex 75 4 212.57 2.42 0.07
6. Age + sex 75 4 212.69 2.65 0.06
Top CDV models
1. Distance to towns + roads + First Nation reserves + age + sex 78 6 230.34 0.00 0.63
2. Distance to First Nation reserves + age + sex 78 6 233.44 1.55 0.29
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For CDV, there were only two models
in the top four DAIC, and the top model
for CDV was a function of all covariates
(DAIC50.00, AIC weight50.628; Table 2).
The null model was similarly poor-fitting as
compared to the CPV model (DAIC58.1).
The top model was significant (x2533.9,
P#0.005) and explained 43.4% of the
variation in CDV (Table 3). Similar to
CPV, there was no support for a random
effect of pack (DAIC55.9). Exposure to
CDV in wolves was more likely for adults
and subadults relative to pups and yearlings
(the intercept), and males had substantially
lower odds of exposure to CDV than
females (Table 3). Exposure to CDV was
also significantly more likely with greater
distances to First Nation reserves, although
the effect size was small (Table 3 and
Fig. 2). Exposure to CDV showed weak,
nonsignificant declines with distance from
roads but remained stable with distance
from towns (Table 3).
DISCUSSION
We found that two common wolf
pathogens had different antibody preva-
lences and age/sex differences, similar to
other studied wolf populations. We found
high CPV antibody prevalences in the
Canadian Rockies, indicating almost all
wolves sampled had been exposed to CPV.
The more virulent CDV had, as expected,
lower antibody prevalence (Table 1).
Compared with other studies, our CPV
antibody prevalence (95%) was higher
than values reported from Montana (John-
son et al., 1994: 65%), Alaska (Zarnke
et al., 2004: 35%), Portugal (Santos et al.,
2009: 32%), and Spain (Sobrino et al.,
2008: 62%) but similar to the 100%
prevalence in wolves in Yellowstone
(Almberg et al., 2009, 2010). In contrast,
prevalence of CDV antibody in our study
(24%) was similar to or slightly higher
(9–24%) than those reported for these
TABLE 3. Measures of model fit (likelihood ratio [LR], chi-square test, and R2) and odds ratios, P-values,
standard error (SE) and P-values for the influence of wolf age class, sex, and distance functions (km) on
prevalence of antibodies to canine parvovirus (CPV) and canine distemper virus (CDV) for the full logistic
regression model from Table 2. Canadian Rockies, Alberta, Canada, 2000–2008. Parameters in bold are
statistically significant at P50.10 from the full model.
LR x2 test
CPV CDV
9.97, P50.083 38.16, P,0.005
R2
0.299 0.434
Odds ratio SE P-value Odds ratio SE P-value
Male 1.22 1.464 0.81 0.225 0.170 0.045
Age $2 8.89 2.36 0.06 3.91 6.97 0.51
Distance to town 1.026 0.087 0.48 0.981 0.022 0.54
Distance to road 1.930 1.09 0.247 0.789 0.096 0.109
Distance to First Nation reserve 0.994 0.21 0.70 1.038 0.013 0.004
FIGURE 2. Observed and predicted canine par-
vovirus (CPV) and canine distemper (CDV) antibody
prevalences as a function of distance to closest First
Nation reserve for gray wolves (Canis lupus) in the
Canadian Rocky Mountains of Alberta and British
Columbia from 2000 to 2008. Only the relationship
between CDV antibody prevalence and distance was
statistically significant (see Table 3).
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same populations (Johnson et al., 1994;
Zarnke et al., 2004; Sobrino et al., 2008;
Almberg et al., 2009) and one population
in Scandinavia (Akerstedt et al., 2010:
10%). There were important and consis-
tent effects of age and sex class on CPV
and CDV antibody prevalence that were
also similar to previous studies. As report-
ed elsewhere, exposure to both CDV and
CPV was higher in wolves .2 yr old
(Zarnke et al., 2004; Sobrino et al., 2008).
The fact that no pups or yearlings showed
exposure to CDV, compared to CPV, is
likely a function of the higher virulence of
CDV and resultant high mortality among
pups, which goes undetected in serologic
tests (Almberg et al., 2009). We found
weaker differences in exposure between
males and females for both CPV and CDV
compared to other studies (Zarnke et al.,
2004).
In contrast to our hypotheses about the
potential effects of human activity on wolf
diseases, we found only weak evidence for
human impacts on exposure to CDV or
CPV, with the potential exception of First
Nation reserves. Very little is known about
the relationships of CPV and CDV to
human activity in North America compared
to studies in African carnivores (Laurenson
et al., 1998; Cleaveland et al., 2000). Our
results suggest that this may be due to
differences in disease ecology between the
two continents. In our study, the preva-
lence of CPV antibody was essentially high
enough such that all wolves were exposed,
and detection of any spatial pattern was
therefore difficult. Zarnke et al. (2004)
found higher antibody prevalences to CPV
and other canine pathogens in remote areas
compared to locations near human settle-
ments in Alaska. We also found that CDV
antibody prevalence increased primarily
further from First Nation reserves, not
closer, as predicted, similar to results of
Zarnke et al. (2004) for CPV. The opposite
effect of First Nation reserves was puzzling,
but it could be explained by higher harvest
of wolves by First Nation trappers near
reserves, leading to lower wolf population
density, and thus lower CDV transmission.
Our results are also consistent with persis-
tence in multihost communities, for exam-
ple, with coyotes, similar to recent results
from Yellowstone National Park (Almberg
et al., 2010). Our ability to discern effects of
humans on carnivore diseases through feral
dogs via indirect means is probably limited
and will require more detailed multihost
studies to understand transmission dynam-
ics (Almberg et al., 2010).
In the larger population of wolves in the
Canadian Rockies, we present the first
information about baseline infection prev-
alence for these two important canine
pathogens. Despite the fact that we found
limited evidence for human effects on wolf
diseases in the Canadian Rockies, canine
diseases may still have potential popula-
tion impacts, for example, through re-
duced pup survival during outbreaks
(Mech and Goyal, 1993; Almberg et al.,
2010). Our results confirm that canine
disease dynamics may be similar to those
known from other populations, for exam-
ple, differences in CPV and CDV expo-
sure, and sex and age differences. The
similarity between our results and results
from nearby recovering wolf populations
in Yellowstone National Park, where a
potential population impact of CDV was
previously detected (Almberg et al., 2009),
suggests that CPV and CDV are significant
and common pathogens of wolf popula-
tions that will be important to understand
for wolf population management (Mech
et al., 2008). Regardless of the potential
role of disease on population dynamics,
the most important demographic effects of
humans are through direct harvest or road
mortality in the Canadian Rockies (Webb
et al., 2011).
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